Hydralazine Hydrochloride Tablet
Product Images NDC 71209-017

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 71209-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cont Label 100mg 1000s Tab

This is a medication called Hydralazine Hydrochloride Tablets USP, with each tablet containing 100mg of the active ingredient. The recommended dosage is not mentioned, and the package insert should be referred to for full prescribing information. The medication should be stored at a temperature between 20° to 25°C (68° to 77°F). It must be kept in a tightly closed and light-resistant container with a child-resistant closure, as required by the USP. The medication is manufactured by Cadila Pharmaceuticals Ltd. in India. The NDC code for the medication is 71209-018-11, and the product comes in a container that holds 1000 tablets.*

FDA Label Image

Cont Label 100mg 100s Tab

Each tablet contains 100 mg hydralazine hydrochloride, USP. This medication is manufactured by Cadila Pharmaceuticals Ltd. and is used for various conditions as prescribed by a doctor. It should be stored at 20° to 25°C (68° to 77°F). This medicine should be kept in a tight, light-resistant container and out of the reach of children. Detailed prescribing information is available in the package insert.*

FDA Label Image

Cont Label 25mg 1000s Tab

This is a medication description for Hydralazine Hydrochloride Tablets USP manufactured by Cadila Pharmaceuticals. The tablet contains 25mg of hydralazine hydrochloride and usual dosage instructions can be found in the package insert or complete prescribing information. The medication should be stored at a temperature of 20 to 25 degrees Celsius and dispensed in a tight, light-resistant container with a high-resistant closure. The medication should be kept out of reach of children. This text contains a National Drug Code (NDC) of 71209-016-11, and the product contains 1000 tablets.*

FDA Label Image

Cont Label 25mg 100s Tab

Hydralazine hydrochloride is the only active ingredient in each tablet contained in this package, with a strength of 25 mg. The full prescribing information can be found in the package insert. Proper storage is advised at a temperature between 20-25°C (68-77°F) and should be kept in a tightly sealed container, away from the children's reach. It is distributed in a child-resistant bottle and follows USP Controlled Room Temperature guidelines. The tablets are produced by Cadila Pharmaceuticals Ltd. with an address in Gujarat State, India. The National Drug Code (NDC) for this product is 71209-016-05, and this specific package contains 100 tablets.*

FDA Label Image

Cont Label 50mg 1000s Tab

Each tablet of HydrALAZINE Hydrochloride Tablets USP contains 50mg of hydralazine hydrochloride. The package insert should be consulted for complete prescribing information and usual dosage. It is recommended that the tablets be stored at controlled room temperature and in a properly sealed, light-resistant container that is inaccessible to children. The medication is manufactured by Cadila Pharmaceuticals Ltd. in India, and each package of 1000 tablets is identified by NDC 71209-017-11.*

FDA Label Image

Cont Label 50mg 100s Tab

Each tablet contains 50 mg hydralazine hydrochloride, USP. The usual dosage can be found in the package insert. Store between 20° to 25°C (68° to 77°F) in a tight, light-resistant container as defined by USP and out of the reach of children. The medication is manufactured by Cadila Pharmaceuticals Ltd in India. NDC 71209-017-05.*

FDA Label Image

Hydralazine-spl-fig1-struct (Hydralazine Spl Fig1 Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.